Empowered Funds’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.4M Sell
269,440
-15,313
-5% -$2.82M 0.27% 68
2026
Q1
$53.7M Buy
284,753
+51,549
+22% +$10.9M 0.34% 39
2025
Q4
$46.3M Buy
233,204
+24,673
+12% +$4.99M 0.79% 18
2025
Q3
$42.3M Buy
208,531
+24,263
+13% +$4.3M 0.43% 25
2025
Q2
$32.4M Buy
184,268
+29,514
+19% +$4.44M 0.37% 40
2025
Q1
$20.8M Buy
154,754
+25,323
+20% +$3.33M 0.3% 53
2024
Q4
$16.3M Buy
129,431
+46,270
+56% +$6.88M 0.24% 69
2024
Q3
$13.8M Buy
83,161
+32,387
+64% +$4.9M 0.22% 86
2024
Q2
$6.75M Sell
50,774
-56,001
-52% -$6.74M 0.12% 228
2024
Q1
$11.2M Buy
+106,775
New +$9.59M 0.2% 102
2022
Q3
Sell
-74,345
Closed -$3.91M 378
2022
Q2
$3.91M Buy
74,345
+53,166
+251% +$3.7M 0.5% 67
2022
Q1
$1.82M Sell
21,179
-3,444
-14% -$283K 0.2% 130
2021
Q4
$2.01M Sell
24,623
-59,418
-71% -$4.34M 0.23% 99
2021
Q3
$5.58M Buy
+84,041
New +$5.96M 0.72% 27

Other funds holding THC

Empowered Funds's THC Position: Q2 2026 in Review

Empowered Funds reduced its Tenet Healthcare (THC) stake by 5.4% in Q2 2026, selling an estimated $2.82M and leaving 269,440 shares worth $50.4M. The position accounts for 0.27% of the portfolio, ranked #68.

Empowered Funds first reported a position in THC in Q3 2021 and has held it in 14 quarters since. The position peaked at $53.7M in Q1 2026. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Empowered Funds held 269,440 shares of Tenet Healthcare worth $50.4M as of Q2 2026.
  • Empowered Funds sold 15,313 Tenet Healthcare shares in Q2 2026, an estimated $2.82M.
  • Tenet Healthcare made up 0.27% of Empowered Funds's portfolio in Q2 2026, its #68 holding.
  • Empowered Funds first reported a position in Tenet Healthcare in Q3 2021 and has held it in 14 quarters since.
  • Empowered Funds's Tenet Healthcare position peaked at $53.7M in Q1 2026.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.